Facebook
X
LinkedIn
ForwardIntroduction to Theranostics: A Multidisciplinary Approach to Clinical Care
Shawnee, KS US
November 19, 2026
This activity will strengthen clinicians’ ability to identify patients who may benefit from theranostic therapies, understand their role in managing prostate cancer and neuroendocrine tumors, and coordinate timely referrals and multidisciplinary care. Through case-based learning and interdisciplinary discussion, participants will gain practical knowledge to support clinical decision-making and improve patient access to theranostic treatments.
Target Audience
This activity is designed for physicians and other healthcare professionals involved in the evaluation, treatment, and referral of patients with cancer, particularly clinicians practicing at hospitals without established theranostics programs.
Learning Objectives
After this activity, participants will be able to:
- Identify clinical characteristics associated with potential eligibility for theranostic evaluation in patients with prostate cancer or neuroendocrine tumors.
- Describe the role of theranostic therapies within current treatment approaches for prostate cancer and neuroendocrine tumors.
- Outline practical steps for referral coordination and ongoing care with a specialized theranostics center.
- Apply clinical findings from a patient case to decisions regarding referral for theranostic evaluation.
- Differentiate the contributions of surgery, medical oncology, and specialized theranostics teams to multidisciplinary patient management.
You may also be interested in
AdventHealth Cancer Institute Shawnee Mission
9110 W 74th St
Shawnee, KS
66203
United States
UNIVERSITY OF CHICAGO FACULTY
Mohammad Atiq, MD
Assistant Professor of Medicine
Assistant Professor of Medicine
Xavier Keutgen, MD
Associate Professor of Surgery
Associate Professor of Radiation and Cellular Oncology
Director, Theranostics Program
Associate Professor of Surgery
Associate Professor of Radiation and Cellular Oncology
Director, Theranostics Program
Chih-Yi “Andy” Liao, MD
Associate Professor of Medicine
Associate Director, Gastrointestinal Oncology
Co-Director, Neuroendocrine Tumor Program
Associate Professor of Medicine
Associate Director, Gastrointestinal Oncology
Co-Director, Neuroendocrine Tumor Program
Disclosure Declarations
As a provider accredited by the ACCME, the University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an educational activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships before the start of the activity.
Additionally, the University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration at first mention and, where appropriate, in the content.
As a provider accredited by the ACCME, the University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an educational activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships before the start of the activity.
Additionally, the University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration at first mention and, where appropriate, in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Participant Credit
Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please note: The credit-claiming process closes 1 month after the activity ends. Requests submitted more than 1 month after the event date may incur additional fees.
Registration: Click the button below for more information!
Claiming Credit: After creating an account or logging in, enter the access code to unlock the credit-claiming process.
Please note: The credit-claiming process closes 1 month after the activity ends. Requests submitted more than 1 month after the event date may incur additional fees.
Please note: The credit-claiming process closes 1 month after the activity ends. Requests submitted more than 1 month after the event date may incur additional fees.
Please login or create an account to proceed.